What happened
After releasing an upbeat earnings report, shares of ResMed (NYSE:RMD), a developer of treatments for sleep-disorder breathing, rose as much as 11% in early morning trading on Tuesday.
So what
Here’s a look at the key figures from ResMed’s fiscal year 2017 second-quarter report that drove Tuesday’s gain.
